Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abikoff H. B., Jensen P. S., Arnold L. L., Hoza B., Hechtman L., Pollack S., Martin D., Alvir J., March J. S., Hinshaw S., Vitiello B., Newcorn J., Greiner A., Cantwell D. P., Conners C. K., Elliott G., Greenhill L. L., Kraemer H., Pelham W. E., Jr., Severe J. B., Swanson J. M., Wells K. and Wigal T. 2002. Observed classroom behavior of children with ADHD: Relationship to gender and comorbidity. J. Abnorm. Child Psychol. 30:349–359
Adewuya A. O. and Famuyiwa O. O. 2006. Attention deficit hyperactivity disorder among Nigerian primary school children: Prevalence and co-morbid conditions. Eur. Child Adolesc. Psychiatr. 16:10–15.Epub 28 November 2006
Adriani W., Canese R., Podo F. and Laviola G. 2006a. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence. Neurotoxicol. Teratol. 29:116–125.Epub 6 December 2006
Adriani W., Leo D., Guarino M., Natoli A., Di C. E., De A. G., Traina E., Testai E., Perrone-Capano C. and Laviola G. 2006b. Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats. Ann. N. Y. Acad. Sci. 1074:52–73
American Academy of Pediatrics 2000. Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105:1158–1170
American Psychiatric Association 1994. Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association, Washington, DC
Arnsten A. F. T. 1998. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn. Sci. 2:436–447
Arnsten A. F. 2006. Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. J. Clin. Psychiatr. 67(Suppl. 8):7–12
Arnsten A. F. and Dudley A. G. 2005. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav. Brain Funct. 1:2
Ashtari M., Kumra S., Bhaskar S. L., Clarke T., Thaden E., Cervellione K. L., Rhinewine J., Kane J. M., Adesman A., Milanaik R., Maytal J., Diamond A., Szeszko P. and Ardekani B. A. 2005.
Attention-deficit/hyperactivity disorder: A preliminary diffusion tensor imaging study. Biol. Psychiatr. 57:448–455
Aston-Jones G., Rajkowski J., Kubiak P. and Alexinsky T. 1994. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J. Neurosci. 14:4467–4480
Attwell D. and Gibb A. 2005. Neuroenergetics and the kinetic design of excitatory synapses. Nat. Rev. Neurosci. 6:841–849
Augustyniak P. N., Kourrich S., Rezazadeh S. M., Stewart J. and Arvanitogiannis A. 2006. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder. Behav. Brain Res. 167:379–382
Bakker S. C., van der Meulen E. M., Oteman N., Schelleman H., Pearson P. L., Buitelaar J. K. and Sinke R. J. 2004. DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families. Am J Med Genet B Neuropsychiatr Genet. 132B:50–52
Barr C. L., Kroft J., Feng Y., Wigg K., Roberts W., Malone M., Ickowicz A., Schachar R., Tannock R. and Kennedy J. L. 2002. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am. J. Med. Genet. 114:255–259
Barry R. J., Johnstone S. J. and Clarke A. R. 2003. A review of electrophysiology in attentiondeficit/hyperactivity disorder: II. Event-related potentials. Clin. Neurophysiol. 114:184–198
Barry R. J., Clarke A. R., McCarthy R., Selikowitz M. and Johnstone S. J. 2005a. EEG coherence adjusted for inter-electrode distance in children with attention-deficit/hyperactivity disorder. Int. J. Psychophysiol. 58:12–20
Barry R. J., Clarke A. R., McCarthy R., Selikowitz M., Johnstone S. J., Hsu C. I., Bond D., Wallace M. J. and Magee C. A. 2005b. Age and gender effects in EEG coherence: II. Boys with attention deficit/hyperactivity disorder. Clin. Neurophysiol. 116:977–984
Bedard A. C., Martinussen R., Ickowicz A. and Tannock R. 2004. Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatr. 43:260–268
Bellgrove M. A., Hawi Z., Gill M. and Robertson I. H. 2006. The cognitive genetics of attention deficit hyperactivity disorder (ADHD): Sustained attention as a candidate phenotype. Cortex. 42:838–845
Berridge C. W., Devilbiss D. M., Andrzejewski M. E., Arnsten A. F., Kelley A. E., Schmeichel B., Hamilton C. and Spencer R. C. 2006. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatr. 60:1111–1120
Biber K., Laurie D. J., Berthele A., Sommer B., Tolle T. R., Gebicke-Harter P. J., van C. D. and Boddeke H. W. 1999. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J. Neurochem. 72:1671–1680
Biederman J. and Faraone S. V. 2005. Attention-deficit hyperactivity disorder. Lancet. 366:237–248
Biederman J., Spencer T. and Wilens T. 2004. Evidence-based pharmacotherapy for attentiondeficit hyperactivity disorder. Int. J. Neuropharmacol. 7:77–97
Bobb A. J., Addington A. M., Sidransky E., Gornick M. C., Lerch J. P., Greenstein D. K., Clasen L. S., Sharp W. S., Inoff-Germain G., Wavrant-De V. F., rcos-Burgos M., Straub R. E., Hardy J. A., Castellanos F. X. and Rapoport J. L. 2005. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134:67–72
Brookes K., Xu X., Chen W., Zhou K., Neale B., Lowe N., Anney R., Franke B., Gill M., Ebstein R., Buitelaar J., Sham P., Campbell D., Knight J., Andreou P., Altink M., Arnold R., Boer F., Buschgens C., Butler L., Christiansen H., Feldman L., Fleischman K., Fliers E., Howe-Forbes R., Goldfarb A., Heise A., Gabriels I., Korn-Lubetzki I., Johansson L., Marco R., Medad S., Minderaa R., Mulas F., Muller U., Mulligan A., Rabin K., Rommelse N., Sethna V., Sorohan J., Uebel H., Psychogiou L., Weeks A., Barrett R., Craig I., Banaschewski T., Sonuga-Barke E., Eisenberg J., Kuntsi J., Manor I., McGuffin P., Miranda A., Oades R. D., Plomin R., Roeyers H., Rothenberger A., Sergeant J., Steinhausen H. C., Taylor E., Thompson M., Faraone S. V. and Asherson P. 2006. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol. Psychiatr. 11:934–953
Bruno K. J., Freet C. S., Twining R. C., Egami K., Grigson P. S. and Hess E. J. 2007. Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD. Neurobiol. Dis. 25:206–216
Castellanos F. X., Giedd J. N., Marsh W. L., Hamburger S. D., Vaituzis A. C., Dickstein D. P., Sarfatti S. E., Vauss Y. C., Snell J. W., Lange N., Kaysen D., Krain A. L., Ritchie G. F., Rajapakse J. C. and Rapoport J. L. 1996. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatr. 53:607–616
Castellanos F. X., Lee P. P., Sharp W., Jeffries N. O., Greenstein D. K., Clasen L. S., Blumenthal J. D., James R. S., Ebens C. L., Walter J. M., Zijdenbos A., Evans A. C., Giedd J. N. and Rapoport J. L. 2002. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. 288:1740–1748
Chabot R. J. and Serfontein G. 1996. Quantitative electroencephalographic profiles of children with attention deficit disorder. Biol. Psychiatr. 40:951–963
Chan S. H., Tai M. H., Li C. Y. and Chan J. Y. 2006. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic. Biol. Med. 40:2028–2039
Cheon K. A., Ryu Y. H., Kim Y. K., Namkoong K., Kim C. H. and Lee J. D. 2003. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur. J. Nucl. Med. 30:306–311
Clark L., Blackwell A. D., Aron A. R., Turner D. C., Dowson J., Robbins T. W. and Sahakian B. J. 2006. Association between response inhibition and working memory in adult ADHD: A link to right frontal cortex pathology? Biol. Psychiatr. 61:1395–1401.Epub 13 October 2006
Clarke A. R., Barry R. J., Bond D., McCarthy R. and Selikowitz M. 2002a. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl). 164:277–284
Clarke A. R., Barry R. J., McCarthy R., Selikowitz M. and Brown C. R. 2002b. EEG evidence for a new conceptualisation of attention deficit hyperactivity disorder. Clin. Neurophysiol 113:1036–1044
Clarke A. R., Barry R. J., McCarthy R., Selikowitz M., Johnstone S. J., Abbott I., Croft R. J., Magee C. A., Hsu C. I. and Lawrence C. A. 2005. Effects of methylphenidate on EEG coherence in attention-deficit/hyperactivity disorder. Int. J. Psychophysiol. 58:4–11
Cook E. H. J., Stein M. A., Krasowski M. D., Cox N. J., Olkon D. M., Kieffer J. E. and Leventhal B. L. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56:993–998
Dell’Anna M. E. 1999. Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behav. Brain Res. 45:125–134
Dell’ Anna M. E., Luthman J., Lindqvist E. and Olson L. 1993. Development of monoamine systems after neonatal anoxia in rats. Brain Res. Bull. 32:159–170
Dickstein S. G., Bannon K., Xavier C. F. and Milham M. P. 2006. The neural correlates of attention deficit hyperactivity disorder: An ALE meta-analysis. J. Child Psychol. Psychiatr. 47:1051–1062
Doroshchuk A. D., Postnov A. I., Afanas’ eva G. V., Budnikov E. I. and Postnov I. 2004. [Decreased ATP-synthesis ability of brain mitochondria in spontaneously hypertensive rats]. Kardiologiia 44:64–65
Dougherty D. D., Bonab A. A., Spencer T. J., Rauch S. L., Madras B. K. and Fischman A. J. 1999. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354:2132–2133
Drouin C., Page M. and Waterhouse B. 2006. Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats. J. Neurophysiol. 96:622–632.Epub 10 May 2006
Durston S., Hulshoff Pol H. E., Schnack H. G., Buitelaar J. K., Steenhuis M. P., Minderaa R. B., Kahn R. S. and van E. H. 2004. Magnetic resonance imaging of boys with attention-deficit/ hyperactivity disorder and their unaffected siblings. J. Am. Acad. Child Adolesc. Psychiatr. 43:332–340
Durston S., Fossella J. A., Casey B. J., Hulshoff Pol H. E., Galvan A., Schnack H. G., Steenhuis M. P., Minderaa R. B., Buitelaar J. K., Kahn R. S. and van E. H. 2005. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol. Psychiatr. 10:678–685
Easton N., Shah Y. B., Marshall F. H., Fone K. C. and Marsden C. A. 2006a. Guanfacine produces differential effects in frontal cortex compared with striatum: Assessed by phMRI BOLD contrast. Psychopharmacology (Berl). 189:369–385
Easton N., Steward C., Marshall F., Fone K. and Marsden C. 2006b. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology 52:405–414.Epub 3 October 2006
El-Faddagh M., Laucht M., Maras A., Vohringer L. and Schmidt M. H. 2004. Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: A longitudinal study from birth to 11 years of age. J. Neural Transm. 111:883–889
Fagundes A. O., Rezin G. T., Zanette F., Grandi E., Assis L. C., Dal-Pizzol F., Quevedo J. and Streck E. L. 2006. Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats. Int. J. Dev. Neurosci. 25:47–51.Epub 22 December 2006
Faraone S. V. 2004. Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr. Clin. North Am. 27:303–321
Faraone S. V. and Khan S. A. 2006. Candidate gene studies of attention-deficit/hyperactivity disorder. J. Clin. Psychiatr. 67(Suppl. 8):13–20
Faraone S. V., Doyle A. E., Mick E. and Biederman J. 2001. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatr. 158:1052–1057
Faraone S. V., Sergeant J., Gillberg C. and Biederman J. 2003. The worldwide prevalence of ADHD: Is it an American condition. World Psychiatr. 2:104–113
Fellner S. K. and Arendshorst W. J. 2002. Store-operated Ca 2+ entry is exaggerated in fresh preglomerular vascular smooth muscle cells of SHR. Kidney Int. 61:2132–2141
Filipek P. A., Semrud-Clikeman M., Steingard R. J., Renshaw P. F., Kennedy D. N. and Biederman J. 1997. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48:589–601
Forssberg H., Fernell E., Waters S., Waters N. and Tedroff J. 2006. Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav. Brain Funct. 2:40
Gainetdinov R. R. and Caron M. G. 2000. An animal model of attention deficit hyperactivity disorder. Mol. Med. Today. 6:43–44
Gainetdinov R. R. and Caron M. G. 2001. Genetics of childhood disorders: XXIV. ADHD, Part 8: Hyperdopaminergic mice as an animal model of ADHD. J. Am. Acad. Child Adolesc. Psychiatr. 40:380–382
Genro J. P., Zeni C., Polanczyk G. V., Roman T., Rohde L. A. and Hutz M. H. 2006. A promoter polymorphism (– C > T) at the dopamine transporter gene is associated with attention deficit/ hyperactivity disorder in Brazilian children. Am. J Med. Genet. B Neuropsychiatr. Genet. 144:215–219
Gibson M. A., Butters N. S., Reynolds J. N. and Brien J. F. 2000. Effects of chronic prenatal ethanol exposure on locomotor activity, and hippocampal weight, neurons, and nitric oxide synthase activity of the young postnatal guinea pig. Neurotoxicol. Teratol. 22:183–192
Glowinski J., Marin P., Tence M., Stella N., Giaume C. and Premont J. 1994. Glial receptors and their intervention in astrocyto-astrocytic and astrocyto-neuronal interactions. Glia. 11:201–208
Gornick M. C., Addington A., Shaw P., Bobb A. J., Sharp W., Greenstein D., Arepalli S., Castellanos F. X. and Rapoport J. L. 2006. Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): An update. Am. J Med. Genet. B Neuropsychiatr. Genet.144B:379–382
Granon S. and Changeux J. P. 2006. Attention-deficit/hyperactivity disorder: A plausible mouse model? Acta Paediatr. 95:645–649
Greenhill L. L. 2001. Clinical effects of stimulant medication in ADHD, in Stimulant drugs and ADHD: Basic and clinical neuroscience, (Solanto M. V., Arnsten A. F. T. and Castellanos F. X., eds), pp. 31–71. Oxford University Press, New York
Hausknecht K. A., Acheson A., Farrar A. M., Kieres A. K., Shen R. Y., Richards J. B. and Sabol K. E. 2005. Prenatal alcohol exposure causes attention deficits in male rats. Behav. Neurosci. 119:302–310
Hill D. E., Yeo R. A., Campbell R. A., Hart B., Vigil J. and Brooks W. 2003. Magnetic resonance imaging correlates of attention-deficit/hyperactivity disorder in children. Neuropsychology 17:496–506
Himelstein J., Newcorn J. H. and Halperin J. M. 2000. The neurobiology of attention-deficit hyperactivity disorder. Front. Biosci. 5:D461–D478
Hobbs M. J., Clarke A. R., Barry R. J., McCarthy R. and Selikowitz M. 2007. EEG abnormalities in adolescent males with AD/HD. Clin. Neurophysiol 118:363–371
Horn J. L., Janicki P. K. and Franks J. J. 1995. Diminished brain synaptic plasma membrane Ca(2 +)-ATPase activity in spontaneously hypertensive rats: Association with reduced anesthetic requirements. Life Sci. 56:L427–L432
Jones S. R., Gainetdinov R. R., Jaber M., Giros B., Wightman R. M. and Caron M. G. 1998. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. USA 95:4029–4034
Jucaite A., Fernell E., Halldin C., Forssberg H. and Farde L. 2005. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity. Biol. Psychiatr. 57:229–238
Karayanidis F., Robaey P., Bourassa M., De K. D., Geoffroy G. and Pelletier G. 2000. ERP differences in visual attention processing between attention-deficit hyperactivity disorder and control boys in the absence of performance differences. Psychophysiology 37:319–333
Keulers E. H., Hendriksen J. G., Feron F. J., Wassenberg R., Wuisman-Frerker M. G., Jolles J. and Vles J. S. 2006. Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: An unblinded clinical trial. Eur. J. Paediatr. Neurol. 11:21–28.Epub 13 December 2006
Kim B. N., Lee J. S., Shin M. S., Cho S. C. and Lee D. S. 2002. Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder. Statistical parametric mapping analysis. Eur. Arch. Psychiatr. Clin. Neurosci. 252:219–225
Kim C. H., Hahn M. K., Joung Y., Anderson S. L., Steele A. H., Mazei-Robinson M. S., Gizer I., Teicher M. H., Cohen B. M., Robertson D., Waldman I. D., Blakely R. D. and Kim K. S. 2006. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc. Natl. Acad. Sci. USA 103:19164–19169
Krause K. H., Dresel S. H., Krause J., Kung H. F. and Tatsch K. 2000. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Lett. 285:107–110
Kuczenski R. and Segal D. S. 1997. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. J. Neurochem. 68:2032–2037
Kuczenski R. and Segal D. S. 2001. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296:876–883
Kuczenski R. and Segal D. S. 2002. Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and crosssensitization to methamphetamine. J. Neurosci. 22:7264–7271
Lahat E., Avital E., Barr J., Berkovitch M., Arlazoroff A. and Aladjem M. 1995. BAEP studies in children with attention deficit disorder. Dev. Med. Child Neurol. 37:119–123
LaHoste G. J., Swanson J. M., Wigal S. B., Glabe C., Wigal T., King N. and Kennedy J. L. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatr. 1:121–124
Lazzaro I., Gordon E., Whitmont S., Meares R. and Clarke S. 2001. The modulation of late component event related potentials by pre-stimulus EEG theta activity in ADHD. Int. J. Neurosci. 107:247–264
Lehohla M., Russell V. and Kellaway L. 2001. NMDA-stimulated Ca 2+ uptake into barrel cortex slices of spontaneously hypertensive rats. Metab. Brain Dis. 16:133–141
Lou H. C., Henriksen L. and Bruhn P. 1984. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch. Neurol. 41:825–829
Luthman J., Fredriksson A., Lewander T., Jonsson G. and Archer T. 1989. Effects of d-amphetamine and methylphentdate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology (Berl). 99:550–557
Maher B. S., Marazita M. L., Ferrell R. E. and Vanyukov M. M. 2002. Dopamine system genes and attention deficit hyperactivity disorder: A meta-analysis. Psychiatr. Genet. 12:207–215
Mannuzza S., Klein R. G. and Moulton J. L., III. 2003. Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. J. Child Adolesc. Psychopharmacol. 13:273–282
Manor I., Corbex M., Eisenberg J., Gritsenkso I., Bachner-Melman R., Tyano S. and Ebstein R. P. 2004. Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am. J. Med. Genet. B Neuropsychiatr. Genet. 127:73–77
Mehta M. A., Goodyer I. M. and Sahakian B. J. 2004. Methylphenidate improves working memory and set-shifting in AD/HD: Relationships to baseline memory capacity. J. Child Psychol. Psychiatr. 45:293–305
Meyer A., Eilertsen D. E., Sundet J. M., Tshifularo J. G. and Sagvolden T. 2004. Cross-cultural similarities in ADHD-like behaviour amongst South African primary school children. S. Afr. J. Psychol. 34:123–139
Mick E., Biederman J., Faraone S. V., Sayer J. and Kleinman S. 2002. Case-control study of attention- deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J. Am. Acad. Child Adolesc. Psychiatr. 41:378–385
Milberger S., Biederman J., Faraone S. V. and Jones J. 1998. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: Findings from a high-risk sample of siblings. J. Clin. Child Psychol. 27:352–358
Moll G. H., Heinrich H., Trott G., Wirth S. and Rothenberger A. 2000. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci. Lett. 284:121–125
Mostofsky S. H., Cooper K. L., Kates W. R., Denckla M. B. and Kaufmann W. E. 2002. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol. Psychiatr. 52:785–794
Nash K., Rovet J., Greenbaum R., Fantus E., Nulman I. and Koren G. 2006. Identifying the behavioural phenotype in fetal alcohol spectrum disorder: Sensitivity, specificity and screening potential. Arch. Women’s Ment. Health 9:181–186
Naumann A., Bellebaum C. and Daum I. 2006a. Cognitive deficits in narcolepsy. J. Sleep Res. 15:329–338
Naumann A., Bellebaum C. and Daum I. 2006b. Cognitive deficits in narcolepsy. J. Sleep Res. 15:329–338
Neuman R. J., Lobos E., Reich W., Henderson C. A., Sun L. W. and Todd R. D. 2006. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol. Psychiatr. 61:1320–1328.Epub 6 December 2006
Nurse B., Russell V. A. and Taljaard J. J. 1984. Alpha- and beta-adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices: Implications for research into depression. Neurochem. Res. 9:1231–1238
Oades R. D. 2000. Differential measures of ‘sustained attention’ in children with attention-deficit/hyperactivity or tic disorders: Relations to monoamine metabolism. Psychiatr. Res. 93:165–178
Ohno Y., Matsuo K., Suzuki H., Tanase H., Serikawa T., Takano T. and Saruta T. 1996. Genetic linkage of the sarco(endo)plasmic reticulum Ca( 2+ )-dependent ATPase II gene to intracellular Ca 2+ concentration in the spontaneously hypertensive rat. Biochem. Biophys. Res. Commun. 227:789–793
Ohno Y., Matsuo K., Suzuki H., Tanase H., Takano T. and Saruta T. 1997. Increased intracellular Ca 2+ is not coinherited with an inferred major gene locus for hypertension (ht) in the spontaneously hypertensive rat. Am. J. Hypertens. 10:282–288
Ohno Y., Suzuki H., Tanase H., Otsuka K., Sasaki T., Suzawa T., Morii T., Ando Y., Maruyama T. and Saruta T. 2005. Quantitative trait loci mapping for intracellular calcium in spontaneously hypertensive rats. Am. J. Hypertens. 18:666–671
Oshima T., Young E. W. and McCarron D. A. 1991. Abnormal platelet and lymphocyte calcium handling in prehypertensive rats. Hypertension 18:111–115
Overmeyer S., Bullmore E. T., Suckling J., Simmons A., Williams S. C., Santosh P. J. and Taylor E. 2001. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol. Med. 31:1425–1435
Park L., Nigg J. T., Waldman I. D., Nummy K. A., Huang-Pollock C., Rappley M. and Friderici K. H. 2005. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol. Psychiatr. 10:572–580
Paz R., Barsness B., Martenson T., Tanner D. and Allan A. M. 2006. Behavioral teratogenicity induced by nonforced maternal nicotine consumption. Neuropsychopharmacology. 32(3):693–699.Epub 22 March 2006
Purper-Ouakil D., Wohl M., Mouren M. C., Verpillat P., Ades J. and Gorwood P. 2005. Metaanalysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr. Genet. 15:53–59
Realmuto G. M., Garfinkel B. D., Tuchman M., Tsai M. Y., Chang P. N., Fisch R. O. and Shapiro S. 1986. Psychiatric diagnosis and behavioral characteristics of phenylketonuric children. J. Nerv. Ment. Dis. 174:536–540
Richelson E. and Pfenning M. 1984. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104:277–286
Rieger M., Mayer G. and Gauggel S. 2003. Attention deficits in patients with narcolepsy. Sleep 26:36–43
Riikonen R. S., Nokelainen P., Valkonen K., Kolehmainen A. I., Kumpulainen K. I., Kononen M., Vanninen R. L. and Kuikka J. T. 2005. Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: A study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry. Biol. Psychiatr. 57:1565–1572
Romano E., Tremblay R. E., Farhat A. and Cote S. 2006. Development and prediction of hyperactive symptoms from 2 to 7 years in a population-based sample. Pediatrics 117:2101–2110
Rubia K., Overmeyer S., Taylor E., Brammer M., Williams S. C., Simmons A. and Bullmore E. T. 1999. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am. J. Psychiatr. 156:891–896
Russell V. A. 2002. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder — the spontaneously hypertensive rat. Behav. Brain Res. 130:191–196
Russell V. A. 2007. Neurobiology of animal models of attention-deficit hyperactivity disorder. J. Neurosci. Meth. 161(2):185–198
Russell V., Allie S. and Wiggins T. 2000. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder — the spontaneously hypertensive rat. Behav. Brain Res. 117:69–74
Russell V. A., Sagvolden T. and Johansen E. B. 2005. Animal models of attention-deficit hyperactivity disorder. Behav. Brain Funct. 1:9
Russell V. A., Oades R. D., Tannock R., Killeen P. R., Auerbach J. G., Johansen E. B. and Sagvolden T. 2006. Response variability in attention-deficit hyperactivity disorder: A neuronal and glial energetics hypothesis. Behav. Brain Funct. 2:30
Sagvolden T. 2000. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 24:31–39
Sagvolden T. 2006. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of attention-deficit/hyperactivity disorder (ADHD). Behav. Brain Funct. 2:41
Sagvolden T., Johansen E. B., Aase H. and Russell V. A. 2005a. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav. Brain Sci. 28:397–419
Sagvolden T., Russell V. A., Aase H., Johansen E. B. and Farshbaf M. 2005b. Rodent models of attention-deficit/hyperactivity disorder. Biol. Psychiatr. 57:1239–1247
Saletu M. T., Anderer P., Saletu-Zyhlarz G. M., Mandl M., Arnold O., Nosiska D., Zeitlhofer J. and Saletu B. 2005. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. Eur. Arch.Psychiatr. Clin. Neurosci. 255:20–32
Scheres A., Milham M. P., Knutson B. and Castellanos F. X. 2006. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol. Psychiatr. 61(5):720–724.Epub 1 September 2006
Schmitz M., Denardin D., Laufer S. T., Pianca T., Hutz M. H., Faraone S. and Rohde L. A. 2006. Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: A case-control study. J. Am. Acad. Child Adolesc. Psychiatr. 45:1338–1345
Semrud-Clikeman M., Steingard R. J., Filipek P., Biederman J., Bekken K. and Renshaw P. F. 2000. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J. Am. Acad. Child Adolesc. Psychiatr. 39:477–484
Shaywitz B. A., Klopper J. H. and Gordon J. W. 1978. Methylphenidate in 6-hydroxydopaminetreated developing rat pups. Effects on activity and maze performance. Arch. Neurol. 35:463–469
Siesser W. B., Zhao J., Miller L. R., Cheng S. Y. and McDonald M. P. 2006. Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes Brain Behav. 5:282–297
Silberstein R. B., Farrow M., Levy F., Pipingas A., Hay D. A. and Jarman F. C. 1998. Functional brain electrical activity mapping in boys with attention- deficit/hyperactivity disorder. Arch. Gen. Psychiatr. 55:1105–1112
Smalley S. L. 1997. Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 60:1276–1282
Snyder S. M. and Hall J. R. 2006. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J. Clin. Neurophysiol. 23:440–455
Sohmer H. and Student M. 1978. Auditory nerve and brain-stem evoked responses in normal, autistic, minimal brain dysfunction and psychomotor retarded children. Electroencephalogr. Clin. Neurophysiol. 44:380–388
Solanto M. V. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention- deficit hyperactivity disorder: A review and integration. Behav. Brain Res. 94:127–152
Stanley J. A., Kipp H., Greisenegger E., MacMaster F. P., Panchalingam K., Pettegrew J. W., Keshavan M. S. and Bukstein O. G. 2006. Regionally specific alterations in membrane phospholipids in children with ADHD: An in vivo 31P spectroscopy study. Psychiatr. Res. 148:217–221
Sullivan J. E. and Chang P. 1999. Review: Emotional and behavioral functioning in phenylketonuria. J. Pediatr. Psychol. 24:281–299
Swanson J. M. and Volkow N. D. 2003. Serum and brain concentrations of methylphenidate: Implications for use and abuse. Neurosci. Biobehav. Rev. 27:615–621
Tabet F., Savoia C., Schiffrin E. L. and Touyz R. M. 2004. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 44:200–208
Tanda G., Pontieri F. E., Frau R. and Di C. G. 1997. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 9:2077–2085
Tannock R. 1998. Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research. J. Child Psychol. Psychiatr. 39:65–99
Tannock R., Schachar R. J., Carr R. P., Chajczyk D. and Logan G. D. 1989. Effects of methylphenidate on inhibitory control in hyperactive children. J. Abnorm. Child Psychol. 17:473–491
Tannock R., Schachar R. and Logan G. 1995. Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children. J. Abnorm. Child Psychol. 23:235–266
Thapar A., Fowler T., Rice F., Scourfield J., van den B. M., Thomas H., Harold G. and Hay D. 2003. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am. J. Psychiatr. 160:1985–1989
Thapar A., O’Donovan M. and Owen M. J. 2005. The genetics of attention deficit hyperactivity disorder. Hum. Mol. Genet. 14 Spec No. 2:R275–R282
Thapar A., Langley K., Asherson P. and Gill M. 2007. Gene–environment interplay in attentiondeficit hyperactivity disorder and the importance of a developmental perspective. Br. J. Psychiatr. 190:1–3
Thatcher R. W., Krause P. J. and Hrybyk M. 1986. Cortico-cortical associations and EEG coherence: A two-compartmental model. Electroencephalogr. Clin. Neurophysiol. 64:123–143
Toga A. W., Thompson P. M. and Sowell E. R. 2006. Mapping brain maturation. Trends Neurosci. 29:148–159
Tsuda K., Tsuda S. and Nishio I. 2003. Role of protein kinase C in the regulation of acetylcholine release in the central nervous system of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 41(Suppl. 1):S57–S60
Ucles P., Lorente S. and Rosa F. 1996. Neurophysiological methods testing the psychoneural basis of attention deficit hyperactivity disorder. Childs Nerv. Syst. 12:215–217
Ueno K., Togashi H., Matsumoto M., Ohashi S., Saito H. and Yoshioka M. 2002. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder. J. Pharmacol. Exp. Ther. 302:95–100
Vaidya C. J., Austin G., Kirkorian G., Ridlehuber H. W., Desmond J. E., Glover G. H. and Gabrieli J. D. 1998. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc. Natl. Acad. Sci. USA 95:14494–14499
Valera E. M., Faraone S. V., Murray K. E. and Seidman L. J. 2006. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol. Psychiatr. 61:1361–1369
van Dyck C. H., Quinlan D. M., Cretella L. M., Staley J. K., Malison R. T., Baldwin R. M., Seibyl J. P. and Innis R. B. 2002. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am. J. Psychiatr. 159:309–312
Volkow N. D., Wang G. J., Fowler J. S., Gatley S. J., Logan J., Ding Y. S., Hitzemann R. and Pappas N. 1998. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatr. 155:1325–1331
Volkow N. D., Wang G., Fowler J. S., Logan J., Gerasimov M., Maynard L., Ding Y., Gatley S. J., Gifford A. and Franceschi D. 2001. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 21:RC121
Volkow N. D., Wang G. J., Fowler J. S. and Ding Y. S. 2005. Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol. Psychiatr. 57:1410–1415
Volkow N. D., Wang G. J., Newcorn J., Fowler J. S., Telang F., Solanto M. V., Logan J., Wong C., Ma Y., Swanson J. M., Schulz K. and Pradhan K. 2007. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34:1182–1190
Xu X., Knight J., Brookes K., Mill J., Sham P., Craig I., Taylor E. and Asherson P. 2005. DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: No evidence for association. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134:115–118
Zhuang X., Oosting R. S., Jones S. R., Gainetdinov R. R., Miller G. W., Caron M. G. and Hen R. 2001. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. USA 98:1982–1987
Acknowledgments
The author wishes to thank the University of Cape Town and South African Medical Research Council for support.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Russell, V.A. (2009). Attention-Deficit/Hyperactivity Disorder as a Metabolic Encephalopathy. In: McCandless, D. (eds) Metabolic Encephalopathy. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79112-8_19
Download citation
DOI: https://doi.org/10.1007/978-0-387-79112-8_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79109-8
Online ISBN: 978-0-387-79112-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)